Goldman Sachs Group Inc Okyo Pharma LTD Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 14, 2024
BUY
$1.31 - $3.74 $25,947 - $74,078
19,807 New
19,807 $33,000
Q1 2023

May 11, 2023
BUY
$1.31 - $3.74 $25,947 - $74,078
19,807 New
19,807 $33,000

About OKYO Pharma Ltd

OKYO Quotes by TradingView
  • Ticker OKYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,144,900
  • Market Cap $22.8M
  • Description
  • OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide pre...
More about OKYO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email